Posturography in MS patients treated with high dose methylprednisolone

Neurol Res. 2016 Jul;38(7):570-4. doi: 10.1080/01616412.2016.1177927. Epub 2016 May 6.

Abstract

Objectives: To evaluate the sensitivity of the balance sway index (SI) to drug-induced functional changes during acute relapse in patients with MS.

Methods: Dynamic posturography was used to derive the SI in 11 healthy subjects and 13 MS patients before and after intravenous high dose methylprednisolone (HDMP).

Results: In both groups, SI was lower in the least demanding task and increased with test complexity. Compared to the healthy group, patients were distinguished by a higher SI both prior to and following administration of HDMP (p < 0.008). However, the effect of the drug on patients' SI was unremarkable. Total Expanded Disability Status Scale score was lower after treatment compared to pre-treatment values (p < 0.001), with significantly lower mean score recorded in patients with pyramidal and cerebellar abnormalities (p = 0.017 and p = 0.011, respectively).

Discussion: The SI measure of dynamic posturography is not sensitive to short-term HDMP-induced functional changes during acute relapse in patients with MS. Further studies are needed to evaluate modified balance protocols and the possible long-term treatment effects of HDMP on SI.

Keywords: Methylprednisolone; Multiple sclerosis; Postural control; Posturography.

MeSH terms

  • Adult
  • Disability Evaluation
  • Female
  • Humans
  • Injections, Intravenous
  • Male
  • Methylprednisolone / therapeutic use*
  • Middle Aged
  • Multiple Sclerosis / complications*
  • Multiple Sclerosis / drug therapy
  • Neuroprotective Agents / therapeutic use*
  • Postural Balance / drug effects*
  • Posture / physiology
  • Sensation Disorders / drug therapy*
  • Sensation Disorders / etiology*
  • Severity of Illness Index
  • Statistics, Nonparametric
  • Treatment Outcome
  • Young Adult

Substances

  • Neuroprotective Agents
  • Methylprednisolone